382150.KQ
Oncocross Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 3,450.00
−2.68%Margins
Gross margin
-311.2%
EBITDA margin
-2644.2%
EBIT margin
-2473.0%
Net margin
-1653.2%
FCF margin
-2414.7%
-48.2%
Return on equity
-20.2%
Return on assets
-70.4%
Return on invested capital
0.01x
Asset turnover
-KRW 7.2B
Cash from operations
KRW 2.1K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026